|
Tuesday, November 15, 2016
Print Current Session:
 |
|
|
Tuesday
SESSION 9:
NEW DEVELOPMENTS IN AAAs AND EVAR
Moderators:Enrico Ascher, MD / Ali F. AbuRahma, MD
|
|
| SESSION 9 SCHEDULE | |
| 6:40 AM - 6:44 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 6:45 AM - 6:50 AM | Indications For Open AAA Repair In The Current Advanced Endovascular Era |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | All AAA Patients Who Need Invasive Treatment Should Be Treated By EVAR If They Have Suitable Anatomy: This Includes Young Patients: This Is Why |
| Presenter(s):Mark Conrad, MD, MMSc | |
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | Propensity Matched Comparison Of EVAR vs. Open Repair In A Large US Medicare Database Show EVAR Benefits Up To 7 Years Later: Nevertheless, Open Repair Is Indicated In Young AAA Patients: This Is Why |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | Interesting Insights From The RCTs Comparing EVAR To Open Repair After 12-15 Years Of Follow-Up: EVAR Benefits Are Not Durable And Reinterventions Continue To Be Needed |
| Presenter(s):Hence J.M. Verhagen, MD, PhD / Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | Long-Term Results Of EVAR With Standard AAA Endografts: How Do These Results Differ From Those In The EVAR RCTs And Why |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | Are Advantages Of Lower AAA Related Mortality From EVAR vs. Open Repair Sustained Better With New Generation Devices: A Critical Comparison Of EVAR 1 vs. The ENGAGE Registry |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 7:21 AM - 7:26 AM | Interesting Key Messages And Highlights From The 15-Year Results Of The EVAR 1 Trial Just Published In The Lancet |
| Presenter(s):Roger M. Greenhalgh, MD | |
| View Slides in PDF | |
| 7:27 AM - 7:33 AM | Panel Discussion |
| Moderator(s): Timur P. Sarac, MD / Gregg S. Landis, MD | |
| 7:33 AM - 7:38 AM | How To Enable EVAR To Be Done For AAAs With Neck Diameters >36 mm: A Combination Of An Endologix AFX Endograft And A Larger Diameter Valiant Tube Graft Makes It Feasible |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| 7:39 AM - 7:44 AM | Value Of Hypnosis For EVAR And Other Endovascular Procedures To Make Them Even Less Invasive: How To Do It |
| Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
| View Slides in PDF | |
| 7:45 AM - 7:50 AM | How Are Long-Term EVAR Outcomes Impacted By Extremely Angled Necks, Conical Necks, And Necks With Circumferential Thrombus: It Doesn’t Seem To Matter If . . . |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 7:51 AM - 7:56 AM | Current Optimal Management Of Inflammatory AAAs: When Endo, When Open |
| Presenter(s):Franco Grego, MD | |
| View Slides in PDF | |
| 7:57 AM - 8:02 AM | Inflammatory AAAs: Open vs. Endo Treatment And Tips And Tricks For Safely Treating With Open Repair |
| Presenter(s):Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 8:03 AM - 8:08 AM | EVAR Techniques For Inflammatory AAAs And Other Rare AAAs Including Behçet’s Disease: How Effective And Durable Are They |
| Presenter(s):Furuzan Numan, MD | |
| View Slides in PDF | |
| 8:09 AM - 8:14 AM | Panel Discussion |
| END OF SESSION 9 | |
| previous | next |